These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26786256)

  • 41. Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study.
    Katoonizadeh A; Sharafkhah M; Ostovaneh MR; Norouzi A; Khoshbakht N; Mohamadkhani A; Eslami L; Gharravi A; Shayanrad A; Khoshnia M; Esmaili S; George J; Poustchi H; Malekzadeh R
    J Viral Hepat; 2016 Oct; 23(10):805-11. PubMed ID: 27126365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses.
    Li X; Xu Y; Dong Y; Yang X; Ye B; Wang Y; Chen Y
    Vaccine; 2018 Apr; 36(18):2442-2449. PubMed ID: 29588118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens.
    Flynn PM; Cunningham CK; Rudy B; Wilson CM; Kapogiannis B; Worrell C; Bethel J; Monte D; Bojan K;
    J Acquir Immune Defic Syndr; 2011 Apr; 56(4):325-32. PubMed ID: 21350366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients.
    Ungulkraiwit P; Jongjirawisan Y; Atamasirikul K; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):680-5. PubMed ID: 17883006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hepatitis B vaccination effectiveness based on anti-HBs antibodies presence in children vertically infected with HIV].
    Ołdakowska A; Marczyńska M
    Przegl Epidemiol; 2010; 64(2):323-8. PubMed ID: 20731246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
    Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effectiveness of vaccination against hepatitis B in HIV infected children].
    Ołdakowska A; Marczyńska M; Szczepańska-Putz M; Kowalik-Mikołajewska B
    Przegl Epidemiol; 2004; 58 Suppl 1():129-33. PubMed ID: 15807171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Seroconversion in response to a reinforced primary hepatitis B vaccination in children with cancer].
    Villena R; Zubieta M; Hurtado C; Salgado C; Silva G; Fernández J; Villarroel M; Fernández M; Brahm J; O'Ryan M; Santolaya ME
    Rev Chil Pediatr; 2015; 86(4):236-43. PubMed ID: 26298296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers.
    Henderson EA; Louie TJ; Ramotar K; Ledgerwood D; Hope KM; Kennedy A
    Infect Control Hosp Epidemiol; 2000 Apr; 21(4):264-9. PubMed ID: 10782589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy.
    Lao-araya M; Puthanakit T; Aurpibul L; Sirisanthana T; Sirisanthana V
    Vaccine; 2007 Jul; 25(29):5324-9. PubMed ID: 17566615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study.
    Morsica G; Bagaglio S; Spagnuolo V; Castagna A; Di Serio C; Galli A; Della Torre L; Andolina A; Pramov A; Uberti-Foppa C
    PLoS One; 2017; 12(9):e0184128. PubMed ID: 28863182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
    Lopes VB; Hassing RJ; de Vries-Sluijs TE; El Barzouhi A; Hansen BE; Schutten M; de Man RA; van der Ende ME
    Vaccine; 2013 Feb; 31(7):1040-4. PubMed ID: 23273969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions.
    van den Berg R; van Hoogstraten I; van Agtmael M
    AIDS Rev; 2009; 11(3):157-64. PubMed ID: 19654857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis A vaccine response in HIV-infected patients: are TWINRIX and HAVRIX interchangeable?
    Jimenez HR; Hallit RR; Debari VA; Slim J
    Vaccine; 2013 Feb; 31(9):1328-33. PubMed ID: 23277097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
    Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
    Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
    Launay O; van der Vliet D; Rosenberg AR; Michel ML; Piroth L; Rey D; Colin de Verdière N; Slama L; Martin K; Lortholary O; Carrat F;
    JAMA; 2011 Apr; 305(14):1432-40. PubMed ID: 21486976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Are teenagers immunized in infancy still protected against hepatitis B?].
    Pokorska-Lis M; Marczyńska M
    Przegl Lek; 2010; 67(1):13-7. PubMed ID: 20509565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.